AHPA Policy prohibits the sale of bulk caffeine

AHPA guidance documents

AHPA produces these guidance documents on specific topics to help the industry comply with applicable laws and regulations and institute best practices that help ensure quality and transparency.

Additional guidance is available in AHPA's Guidance Policies >>

AHPA Policy prohibits the sale of bulk caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging

Published: Tuesday, March 24, 2015

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers). The policy is effective immediately and has been included in AHPA's Code of Ethics and Business Conduct. 

The AHPA Board's action came in the wake of recent reports associating serious injury and death with use of pure caffeine purchased by consumers in bulk packaging. These events also prompted several U.S. Senators to urge the Food and Drug Administration (FDA) to ban sale of bulk caffeine. See AHPA Legal Alert, 1/27/2015

AHPA members agree to comply with the Association's Code of Ethics and Business Conduct, which contains trade requirements adopted by the association. Revised on an ongoing basis, AHPA's trade requirements are created and codified when the industry determines that policies beyond those mandated by federal laws serve the common interest of the industry and our consumers.

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.